Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07122479 · ClinicalTrials.gov registry record · NA
Prevention of Hospital Acquired Deconditioning in Hospitalized Acute Leukemia Patients
A NA study of Acute Leukemia, sponsored by Northwell Health.
- Active
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 2
- Study locations
NCT07122479: Active NA study of Acute Leukemia, sponsored by Northwell Health.
NCT07122479 is a NA study of Acute Leukemia that is active but no longer recruiting, run by Northwell Health. The registered enrollment target is 50 participants, below the 462-participant average among 37 other Acute Leukemia trials with a reported enrollment target (89% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07122479, a NA study of Acute Leukemia, is active but no longer recruiting, sponsored by Northwell Health.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study aims to decrease the incidence of hospital acquired deconditioning (HAD) and to help standardize daily physical exercise monitoring in acute leukemia patients with anticipated prolonged duration of hospital stay. The investigators hypothesize that implementing a patient-reported adherence log of their recommended standard daily set of exercises will help reduce proportion of hospital acquired deconditioning in acute leukemia patients. The investigators also hypothesize that less adherent patients will have more inpatient hospital related events and decreased health related quality of life.
Primary Outcome
daily log of physical exercise adherence and 3) standardize the monitoring of physical exercise by the healthcare team by its inclusion in daily progress notes.
Conditions Studied
Interventions
- OTHER Three-Pronged Approach to Reduce Hospital Acquired Deconditioning
Study Locations (2)
New York
- North Shore University Hospital (NSUH) - Manhasset
- Zuckerberg Cancer Center - New Hyde Park
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2023-10-27 |
| Est. Completion | 2025-08 |
| Phase | NA |
What the registry record for NCT07122479 still lists
NCT07122479 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 462-participant average among 37 other Acute Leukemia trials with a reported enrollment target (89% lower).
The record links to 1 condition, with Acute Leukemia appearing as the primary indexed condition, and to 1 intervention - of which Three-Pronged Approach to Reduce Hospital Acquired Deconditioning is the first listed.
NCT07122479 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT07122479 about?
NCT07122479 is a clinical study titled "Prevention of Hospital Acquired Deconditioning in Hospitalized Acute Leukemia Patients". This study aims to decrease the incidence of hospital acquired deconditioning (HAD) and to help standardize daily physical exercise monitoring in acute leukemia patients with anticipated prolonged duration of hospital stay. The investigators hypothesize that implementing a patient-reported adherence...
What is the current status of trial NCT07122479?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2023-10-27. Estimated completion is 2025-08.
What conditions does trial NCT07122479 study?
This clinical trial studies the following conditions: Acute Leukemia.
What interventions are being tested in trial NCT07122479?
The interventions under investigation include: Three-Pronged Approach to Reduce Hospital Acquired Deconditioning (OTHER).
Who is sponsoring clinical trial NCT07122479?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07122479 being conducted?
This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Leukemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07122479's enrollment target sits among peer trials
50 25th of 37 higher than 11 of 37 other Acute Leukemia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Acute Leukemia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Brain MRF in Children, Adolescents and Young Adults With Acute Leukemia
RECRUITING · NA
-
Standard-of-Care Reduced-Intensity Conditioning (RIC) With 200 Versus 400 cGy of Total Body Irradiation (TBI) in Patients With Acute Leukemia Undergoing First Allogeneic Blood or Marrow Transplantation (BMT)
RECRUITING · NA
-
CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT
RECRUITING · NA
-
Tools for Reducing Inequity in Acute Leukemia (TRIAL): Beta Testing
RECRUITING · NA
-
A High Intensity Electronic Health Intervention for the Reduction of Learning Disparities in Childhood Cancer Survivors
ACTIVE NOT RECRUITING · NA
-
High-Intensity Parent Intervention Program in Improving Learning and School Functioning in Latino Children With Acute Leukemia or Lymphoblastic Lymphoma
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI